Nasopharyngeal Carcinoma: Clinical Achievements and Considerations Among Treatment Options
Nasopharyngeal carcinoma (NPC) is a severe malignancy arising from the nasopharyngeal epithelium and is southern China’s third most common cancer. With the advancement of treatment methods, early-stage NPC patients usually have a better prognosis and more prolonged survival period than those with ot...
Enregistré dans:
Auteurs principaux: | Zheran Liu, Ye Chen, Yonglin Su, Xiaolin Hu, Xingchen Peng |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a40675281eb54a84a44c230d2d55c73f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Nasopharyngeal carcinoma – Improving cure with technology and clinical trials
par: Raymond K. Tsang
Publié: (2020) -
Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era
par: Sarbani Ghosh-Laskar, et autres
Publié: (2020) -
Dosimetric Comparison of Helical Tomotherapy, Volume-Modulated Arc Therapy, and Fixed-Field Intensity-Modulated Radiation Therapy in Locally Advanced Nasopharyngeal Carcinoma
par: Shan Lu, et autres
Publié: (2021) -
Development of a Nomogram Model for Treatment of Elderly Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
par: Jia Kou, et autres
Publié: (2021) -
Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era
par: Su Z, et autres
Publié: (2020)